Recombinant LRP6 抗体 (pSer1490)
Our Local Distributor
北京 101111
Quick Overview for Recombinant LRP6 抗体 (pSer1490) (ABIN7879710)
抗原
See all LRP6 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- pSer1490
-
原理
- Phospho-LRP6 (Ser1490) Antibody / Low density lipoprotein receptor related protein 6
-
纯化方法
- Affinity chromatography
-
免疫原
- A synthesized peptide derived from human Phospho-LRP6 (S1490) was used as the immunogen for the Phospho-LRP6 (Ser1490) antibody.
-
亚型
- IgG
-
-
anti-Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) (AA 1198-1370) antibody
LRP6 适用: 人 ELISA, FACS 宿主: 小鼠 Monoclonal 1A3F5 unconjugated
anti-Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) (AA 1546-1560) antibodyVerified LRP6 适用: 人 IHC, ELISA, FACS 宿主: 山羊 Polyclonal unconjugated
anti-Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) (C-Term) antibodyLRP6 适用: 人, 小鼠, 大鼠 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) (AA 1531-1560), (C-Term) antibodyLRP6 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal RB01837 unconjugated
anti-Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) (pSer1490) antibodyLRP6 适用: 人, 小鼠, 大鼠 WB, ELISA, IF (p), IF (cc), IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) (AA 981-1213) antibodyLRP6 适用: 人 WB, IHC, ICC, IP 宿主: 兔 Polyclonal unconjugated
anti-Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) (AA 20-150) antibodyLRP6 适用: 人 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) (AA 1531-1560) antibodyLRP6 适用: 人 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) (AA 981-1213) antibodyLRP6 适用: 人 WB, IHC, ICC, IP 宿主: 小鼠 Monoclonal C3 unconjugated
anti-Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) (C-Term) antibodyLRP6 适用: 人 WB, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal dilution of the Phospho-LRP6 (Ser1490) antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store the Phospho-LRP6 (Ser1490) antibody at -20oC.
-
-
- LRP6 (Low Density Lipoprotein Receptor-Related Protein 6 (LRP6))
-
别名
- LRP6
-
背景
-
Phospho-LRP6 (Ser1490) antibody detects the phosphorylated form of Low density lipoprotein receptor related protein 6, encoded by the LRP6 gene. LRP6 is a single pass transmembrane receptor that serves as a critical co receptor in the canonical Wnt signaling pathway. This receptor works together with the Frizzled family of proteins to transmit Wnt signals into the cell, leading to stabilization of beta catenin and activation of Wnt target genes. Phosphorylation at serine 1490 is a key activation step that amplifies the signaling cascade, and Phospho-LRP6 (Ser1490) antibody provides a precise tool to study Wnt pathway activation in both normal physiology and disease contexts.
Low density lipoprotein receptor related protein 6 is phosphorylated by kinases such as GSK3 and CK1 following Wnt ligand binding. Serine 1490 is one of the critical sites required for recruitment of the cytoplasmic effector Dishevelled and for inhibition of the beta catenin destruction complex. Research using Phospho-LRP6 (Ser1490) antibody has shown that phosphorylation at this site acts as a molecular switch, turning on downstream signaling. Without phosphorylation at serine 1490, Wnt mediated gene expression is severely impaired, demonstrating the importance of this modification in developmental and disease related signaling events.
Aberrant Wnt signaling is implicated in multiple cancers, including colorectal carcinoma, breast cancer, and hepatocellular carcinoma. Overexpression or hyperactivation of LRP6 contributes to increased beta catenin stabilization, driving oncogenic transcriptional programs. Studies employing Phospho-LRP6 (Ser1490) antibody have revealed that elevated phosphorylation correlates with poor prognosis and aggressive tumor progression. Beyond cancer, abnormal regulation of LRP6 phosphorylation is also associated with bone disorders, atherosclerosis, and neurodegenerative disease, highlighting the broad relevance of this receptor.
Phospho-LRP6 (Ser1490) antibody is widely applied in western blotting, immunohistochemistry, and immunofluorescence. Western blotting allows quantification of phosphorylated versus unphosphorylated forms, providing a readout of Wnt activation. Immunohistochemistry demonstrates tissue specific activation of Wnt signaling, while immunofluorescence visualizes membrane localized phosphorylation events in cell culture models. Researchers studying embryonic development, stem cell biology, and tumor progression use Phospho-LRP6 (Ser1490) antibody to dissect pathway activity with high specificity.
By providing validated reagents such as Phospho-LRP6 (Ser1490) antibody, NSJ Bioreagents supports investigations into Wnt pathway regulation, cancer mechanisms, and developmental biology. The ability to detect this key phosphorylation event allows scientists to better understand how external cues are transduced into cellular responses that govern growth, survival, and differentiation. -
UniProt
- O75581
-
途径
- WNT signaling, Tube Formation
抗原
-
